Miguel Martin Selected Research

DNA (Deoxyribonucleic Acid)

1/2017	Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
8/2016	A Cross-Sectional Comparison of Druggable Mutations in Primary Tumors, Metastatic Tissue, Circulating Tumor Cells, and Cell-Free Circulating DNA in Patients with Metastatic Breast Cancer: The MIRROR Study Protocol.
1/2016	Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miguel Martin Research Topics

Disease

127	Breast Neoplasms (Breast Cancer) 05/2024 - 01/2002
50	Neoplasms (Cancer) 01/2024 - 01/2002
12	Neoplasm Metastasis (Metastasis) 05/2024 - 09/2012
10	Triple Negative Breast Neoplasms 01/2024 - 01/2016
10	Neutropenia 11/2023 - 11/2016
9	Fatigue 01/2024 - 04/2011
7	Disease Progression 06/2021 - 08/2007
7	Febrile Neutropenia 01/2020 - 02/2008
6	Diarrhea 01/2024 - 01/2010
4	Melanoma (Melanoma, Malignant) 01/2024 - 10/2014
4	Colorectal Neoplasms (Colorectal Cancer) 01/2015 - 04/2011
3	Leukopenia 01/2023 - 11/2016
3	Pain (Aches) 12/2020 - 09/2012
3	Nausea 02/2020 - 03/2016
3	Anemia 02/2020 - 11/2016
3	Pathologic Complete Response 01/2020 - 11/2010
3	Exanthema (Rash) 05/2015 - 01/2013
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2006
2	Circulating Neoplastic Cells 01/2023 - 08/2016
2	Vomiting 12/2017 - 03/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015 - 10/2014
2	Hypertension (High Blood Pressure) 01/2015 - 04/2011
2	Cardiotoxicity 12/2012 - 10/2011
2	Heart Failure 10/2011 - 12/2004

Drug/Important Bio-Agent (IBA)

40	Hormones (Hormone)IBA 05/2024 - 04/2011
28	ErbB Receptors (EGF Receptor)IBA 01/2024 - 11/2009
27	Trastuzumab (Herceptin)FDA Link 11/2023 - 01/2010
22	Docetaxel (Taxotere)FDA Link 01/2021 - 03/2003
19	abemaciclibIBA 05/2024 - 01/2016
14	palbociclibIBA 01/2024 - 01/2016
14	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2002
14	taxaneIBA 10/2021 - 01/2002
13	Estrogen ReceptorsIBA 01/2024 - 06/2008
13	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2003
12	AnthracyclinesIBA 01/2021 - 01/2002
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013 - 01/2002
10	Taxoids (Taxanes)IBA 01/2021 - 07/2006
9	neratinibIBA 01/2023 - 12/2013
9	human ERBB2 proteinIBA 01/2023 - 11/2014
9	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2011
8	pertuzumabIBA 04/2023 - 01/2016
8	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2009
7	Cyclin-Dependent Kinase 4IBA 05/2024 - 01/2020
7	Letrozole (Femara)FDA LinkGeneric 01/2024 - 11/2016
7	ribociclibIBA 01/2023 - 10/2017
7	Lapatinib (GW572016)FDA Link 03/2016 - 01/2013
7	Fluorouracil (Carac)FDA LinkGeneric 01/2015 - 06/2005
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2010
6	Progesterone Receptors (Progesterone Receptor)IBA 06/2021 - 03/2009
6	Vinorelbine (Navelbine)FDA LinkGeneric 02/2020 - 01/2002
6	Ado-Trastuzumab EmtansineIBA 11/2019 - 01/2017
5	Fulvestrant (Faslodex)FDA Link 12/2020 - 10/2010
5	Phenobarbital (Luminal)FDA Link 01/2019 - 03/2009
4	Aromatase InhibitorsIBA 05/2024 - 01/2019
4	Tumor Biomarkers (Tumor Markers)IBA 11/2023 - 01/2019
4	Messenger RNA (mRNA)IBA 01/2023 - 05/2008
4	Gemcitabine FDA Link 02/2020 - 05/2013
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2010
4	Pemetrexed (MTA)FDA Link 05/2013 - 01/2006
4	Bevacizumab (Avastin)FDA Link 01/2013 - 01/2011
3	Tamoxifen FDA LinkGeneric 05/2024 - 01/2021
3	Epidermal Growth Factor (EGF)IBA 04/2024 - 12/2013
3	Alanine Transaminase (SGPT)IBA 12/2022 - 01/2018
3	VaccinesIBA 01/2022 - 01/2011
3	talazoparibIBA 01/2022 - 01/2018
3	eribulin FDA Link 02/2020 - 01/2018
3	Cytotoxins (Cytolysins)IBA 01/2018 - 07/2006
3	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2011 - 01/2002
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2009 - 02/2008
2	Antineoplastic Agents (Antineoplastics)IBA 07/2023 - 08/2021
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2022 - 10/2021
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 01/2016
2	Poly Adenosine Diphosphate RiboseIBA 02/2020 - 01/2018
2	Denosumab FDA Link 01/2020 - 09/2012
2	Monoclonal AntibodiesIBA 01/2020 - 01/2011
2	Immune Checkpoint InhibitorsIBA 11/2019 - 01/2016
2	RNA (Ribonucleic Acid)IBA 11/2019 - 04/2014
2	ParaffinIBA 11/2019 - 08/2016
2	Formaldehyde (Formol)FDA Link 11/2019 - 08/2016
2	Estrogens (Estrogen)FDA Link 01/2019 - 08/2010
2	PlatinumIBA 01/2017 - 01/2016
2	IgA receptor (protein B)IBA 03/2015 - 10/2014
2	Glycoproteins (Glycoprotein)IBA 03/2015 - 10/2014
2	RamucirumabIBA 01/2015 - 11/2009
2	ProdrugsIBA 01/2015 - 04/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2011 - 01/2011
2	TubulinIBA 08/2010 - 08/2007
2	Sunitinib (Sutent)FDA Link 05/2010 - 01/2010
2	VitaminsIBA 08/2009 - 01/2006
2	Thymidine PhosphorylaseIBA 06/2007 - 01/2002

Therapy/Procedure

69	Therapeutics 05/2024 - 12/2004
36	Drug Therapy (Chemotherapy) 05/2024 - 01/2002
13	Adjuvant Chemotherapy 01/2023 - 06/2005
12	Neoadjuvant Therapy 04/2023 - 04/2011
3	Drug Tapering 04/2024 - 01/2010
3	Immunotherapy 09/2023 - 11/2016
2	Aftercare (After-Treatment) 01/2024 - 01/2018
2	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 01/2013